Severity and prevalence of (COVID ۱۹) infection among patients with respiratory symptoms, and history of four doses of vaccination

  • سال انتشار: 1401
  • محل انتشار: پنجمین همایش بین المللی زیست شناسی و علوم زمین
  • کد COI اختصاصی: BIOLOGY05_197
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 94
دانلود فایل این مقاله

نویسندگان

Arash Letafati

Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Elnaz Khodadoust Soufiani

Department of Medical Laboratory Science, Faculty of Para Medicine, Islamic Azad University, Tehran Medical Branch, Tehran, Iran

Zahra Heidary

Department of Virology, School of Public Health, Ahvaz University of Medical Sciences, Ahvaz, Iran

Kimia Mohajeri

Department of Microbiology, School of Basic Sciences, Islamic Azad University, Tehran, Iran

Sepideh Saeb

Department of Virology, Lorestan University of Medical Sciences, Khorramabad, Iran

چکیده

Acute respiratory infection (ARI) is a severe infection that affects a person's respiratory systemand causes breathing problems. Coronaviridae is one of the viral families that cause respiratoryinfections in birds and mammals. The efficiency of vaccination against COVID-۱۹ infection isundeniable so this study aimed to evaluate the symptoms of SARS-CoV-۲ in people whoreceived four doses of the Sinopharm vaccine. This study evaluated the prevalence and severityof COVID-۱۹ infection in vaccinated people with four doses of sinopharm vaccine. All sampleswere collected from patients with respiratory symptoms who were referred to Besat hospital,Tehran, Iran. From ۲۹۰ patients with respiratory symptoms, ۱۰۹ patients were positive forCOVID-۱۹ infection with a history of four doses of Sinopharm vaccine and the most commonclinical symptom of infection were cough, runny nose, and fever but the hospitalization rate wasvery low. Although vaccination can’t prevent infection with SARS-CoV-۲, but against COVID-۱۹ infection seems to be beneficial in reducing symptoms and hospitalization rate, especially ifthey have received a forth booster dose.

کلیدواژه ها

Respiratory Tract Infection, COVID-۱۹, Vaccination, Sinopharm

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.